Literature DB >> 23499728

Focus: quantitative HBsAg measurement as a new surrogate marker for assessment of hepatic fibrosis in HBeAg+ chronic hepatitis B.

Daniel Shouval1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499728     DOI: 10.1016/j.jhep.2013.03.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?

Authors:  Yoshihiko Yano; Yasushi Seo; Hiroki Hayashi; Yuri Hatazawa; Hirotaka Hirano; Akihiro Minami; Yuki Kawano; Masaya Saito; Toshiaki Ninomiya; Masahiko Sugano; Hajime Yamada; Naoto Kitajima; Seitetsu Yoon; Yoshitake Hayashi
Journal:  Biomed Rep       Date:  2017-07-18

Review 2.  Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment.

Authors:  Hans L Tillmann
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

3.  Development and validation of a prediction score for complications after hepatectomy in hepatitis B-related hepatocellular carcinoma patients.

Authors:  Haiqing Wang; Jian Yang; Jiayin Yang; Li Jiang; Tianfu Wen; Wentao Wang; Mingqing Xu; Bo Li; Lunan Yan
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

4.  Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive.

Authors:  Hong Wang; Ying Zhou; Rong Yan; Guo Qing Ru; Li Li Yu; Ming Shan Wang; Mei Juan Chen
Journal:  Oncotarget       Date:  2017-10-24

5.  A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.

Authors:  Ling Li; Yongan Ye; Yun Ran; Shuyan Liu; Qiyuan Tang; Yaya Liu; Xuejiao Liao; Juanjuan Zhang; Guohui Xiao; Jian Lu; Guoliang Zhang; Qing He; Shiping Hu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

6.  Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?

Authors:  Antonio Bertoletti; Adam J Gehring
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.